The development of PI3K inhibitors as anticancer drugs
Phosphatidylinositol 3-kinases (PI3Ks) are a lipid enzyme family that are vitally important regulators of intracellular signalling pathways which control cellular activities including cell survival, growth and proliferation. Deregulation of the PI3K signalling cascade has been observed in a broad ra...
Main Author: | |
---|---|
Other Authors: | |
Published: |
ResearchSpace@Auckland
2011
|
Online Access: | http://hdl.handle.net/2292/6440 |